Cargando…
Engineered Bacteria for Short-Chain-Fatty-Acid-Repressed Expression of Biotherapeutic Molecules
Short-chain fatty acids (SCFA) such as propionate and butyrate are critical metabolites produced by the gut microbiota. Microbiome dysbiosis resulting in altered SCFA profiles is associated with certain diseases, including inflammatory bowel diseases (IBD), characterized by a reduction in butyrate c...
Autores principales: | Serebrinsky-Duek, Kineret, Barra, Maria, Danino, Tal, Garrido, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101121/ https://www.ncbi.nlm.nih.gov/pubmed/36939337 http://dx.doi.org/10.1128/spectrum.00049-23 |
Ejemplares similares
-
Microbial interactions and the homeostasis of the gut microbiome: the role of Bifidobacterium
por: Martin, Alberto J.M., et al.
Publicado: (2023) -
Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases
por: Barra, Maria, et al.
Publicado: (2020) -
Engineered Bacteria-Based Living Materials for Biotherapeutic Applications
por: Omer, Rabia, et al.
Publicado: (2022) -
Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics
por: Chang, Rachel Yoon Kyung, et al.
Publicado: (2022) -
Engineering fungal de novo fatty acid synthesis for short chain fatty acid production
por: Gajewski, Jan, et al.
Publicado: (2017)